Charles River Laboratories International, Inc.
CRL
$291.76
$9.423.34%
NYSE
| 06/27/2026 | 03/28/2026 | 12/27/2025 | 09/27/2025 | 06/28/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.48M | -14.84M | -276.56M | 54.42M | 52.33M |
| Total Depreciation and Amortization | 65.79M | 67.15M | 124.78M | 14.16M | 79.81M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 115.59M | 94.85M | 292.53M | 150.39M | 61.30M |
| Change in Net Operating Assets | -176.00K | -106.08M | 6.77M | -5.15M | 11.17M |
| Cash from Operations | 179.73M | 41.08M | 147.52M | 213.83M | 204.60M |
| Capital Expenditure | -31.11M | -55.91M | -88.95M | -35.58M | -35.30M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -62.25M | -405.01M | -- | -- | -- |
| Divestitures | 116.47M | 60.10M | 0.00 | 0.00 | 0.00 |
| Other Investing Activities | 4.98M | -7.03M | -3.86M | 1.88M | -2.04M |
| Cash from Investing | 28.10M | -407.85M | -92.81M | -33.70M | -37.34M |
| Total Debt Issued | 352.80M | 912.46M | 156.67M | 107.50M | 547.02M |
| Total Debt Repaid | -390.25M | -355.68M | -207.82M | -253.79M | -738.31M |
| Issuance of Common Stock | 397.00K | 1.22M | 711.00K | 2.00K | 1.00K |
| Repurchase of Common Stock | -115.60M | -208.29M | -96.00K | -93.00K | -7.35M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -12.01M | -2.00M | -1.34M | -6.23M | -28.28M |
| Cash from Financing | -164.66M | 347.72M | -51.86M | -152.62M | -226.92M |
| Foreign Exchange rate Adjustments | -781.00K | 1.25M | 3.93M | -3.03M | 12.67M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 42.38M | -17.80M | 6.78M | 24.48M | -46.99M |